Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


苹果哪个vnp好用

July 31, 2025 - Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results July 7, 2025 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2025 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

苹果哪个vnp好用

苹果哪个vnp好用

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

苹果哪个vnp好用

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
云帆加速器app下载  极光佛跳墙官网  turbo梯子  ss节点分享  佛跳墙2025永久蓝奏  下载了老王加速器还是上不了